IFNA1 and neoplasm: While the anti-PD-L1 antibody failed to control tumor growth, both the heterodimer and homodimer forms of the IFNα-anti-PD-L1 fusion protein overcame anti-PD-L1 resistance and induced complete tumor regression in most of the treated mice (Fig. 2e).